Bile acids have been considered intestinal tumor promoters, and because they are natural ligands for the nuclear receptor FXR, we examined the role of FXR in intestinal tumorigenesis.
Introduction
The pathogenesis of colon cancer initially includes one or more genetically altered cells and requires many years to develop through a multistep process, which allows nutrients to modify the progression of the disease (1) . Bile acids are cholesterol derivatives, necessary for the solubilization and absorption of lipids and lipid soluble vitamins in the gut (2) . Studies in rodent models of intestinal cancer and human epidemiologic studies have linked elevated levels of bile acids to an increased incidence of colorectal cancer (3) . Several pathways have been proposed to mediate the tumor promoting activity of bile acids in the postinitiation phase of intestinal tumorigenesis; however, the precise mechanism remains elusive. Bile acids are the natural ligands for the nuclear farnesoid X receptor (FXR, NR1H4; refs. 4, 5) , a member of the nuclear hormone receptor family of transcription factors. FXR is highly expressed in the entero-hepatic system where it transcriptionally regulates bile acid and lipid metabolism. In the present study, we sought to investigate whether FXR plays a role in the progression of intestinal tumorigenesis. First, we show that FXR expression is restricted to the differentiated compartment of the intestinal mucosa and is low in intestinal tumors of both mice and humans. Second, we show that loss of FXR in two mouse models of intestinal tumorigenesis results in early mortality and increased tumor progression. Third, we provide evidence that the susceptibility of FXR À/À mice to intestinal tumorigenesis is unaffected by cholestyramine-mediated reduction in circulating bile acid levels, indicating that loss of FXR and not merely elevated bile acid concentrations increases susceptibility to tumorigenesis. Finally, using a xenograft model, we show that reactivation of FXR via adenoviral infection blocks tumor growth through the induction of proapoptotic pathways and repression of antiapoptotic as well as proinflammatory genes.
Materials and Methods
Mice. Pure strain C57BL/6J FXR À/À mice were kindly provided by Adenoviral constructs. VP16 and VP16FXR adenovirus (AdVP16 and AdVP16FXR) were generated using the Viral Power Adenoviral Expression System (Invitrogen). Briefly, to generate the VP16 adenovirus, the VP16 sequence (0.3 kb) from the pCMX-VP16 plasmid was subcloned into the pENTR4 shuttle vector using Sal I and XhoI restriction sites. Indeed, this shuttle vector containing VP16 was recombinated with the destination vector pAd/CMV/V5DEST. To generate the AdVP16FXR, the FXR sequence from the pCMX-VP16FXR (1.7 kb, kindly provided by Dr. D. Mangelsdorf) vector was subcloned into the pENTR4-VP16 shuttle vector using KpnI and BamHI restriction sites. Then, the pENTR4-VP16 and the pENTR4-VP16FXR Histology and immunohistochemistry. Tissue specimens were fixed in 10% formalin for 12 to 24 h, dehydrated, and paraffin embedded. Standard immunohistochemical procedures were performed. Briefly, 5-Am-thick sections were treated with 3% hydrogen peroxide for 5 min, to quench endogenous peroxidase, and subjected to antigen retrieval by boiling the slides in antigen unmasking solution (Vector-Laboratories, Inc.) for 15 min according to manufacturer's instructions. Sections were sequentially incubated for 60 min at room temperature in 50% nonimmune serum ( from the host animal in which the secondary antibody was raised) in PBS (to avoid unspecific signal) and overnight at 4jC with the primary antibodies (rabbit polyclonal Ki67 from AbCam; FXR antibody was a generous gift from Phenex Pharmaceutical AG; rabbit polyclonal p21, C-19 from Santa Cruz; rat antimouse CD18 from BD Biosciences; human active h-catenin dephosphorylated on Ser37 and Thr41 from Upstate). Sections were washed 10 min in PBS and incubated for 30 min at room temperature with the secondary biotinylated antibody (Vector Laboratories). After several washing steps with PBS (3 washes, 5 min each), sections were incubated with the avidin-biotin complex (Vector Laboratories) for 30 min at room temperature. After washing in PBS, the peroxidase reaction was developed by incubation with 3,3 ¶-diaminobenzidine (Sigma-Aldrich). Counterstaining was carried out with methylene-blue (Sigma-Aldrich). For negative controls, 1% nonimmune serum in PBS replaced the primary antibodies.
Aberrant crypt foci analysis. The aberrant crypt foci (ACF) detection and analysis was carried out as previously described (7). Briefly, after gross visual inspection, mouse colons were stored at À80jC until use. At the time of examination for ACF, colons were thawed in 2.5% formalin solution at room temperature, then fixed in 70% ethanol at 4jC for 30 min, and stained with 0.2% methylene blue for 2 min. Stained colons were transferred to 2.5% formalin solution at room temperature for up to 1 h and then examined in their entirety under a light microscope at Â40 or Â100 magnification, at which time the number and location of ACF were recorded.
Proliferation assay. LS174T were seeded at 1. Apoptotic assay. LS174T were seeded at 6 Â 10 5 cells per well in a 12-multiwell plate and infected with 100 MOI of AdVP16 or AdVP16FXR for 48 h. Then, apoptosis was investigated by determination of cytoplasmatic histone-associated DNA fragments using the cell death detection ELISA kit (Roche) following the manufacturer's instruction. Stainings for Annexin V-Alexa 568 (Roche) was carried out according to the manufacturer's protocols. Cells were finally washed with PBS and the coverslips mounted with MowiolTM (Calbiochem). For images examined at Zeiss LSM 510 confocal microscope (LSCM; Â1,260 magnification), optical sections were obtained with a Â63 oil immersion objective, at a definition of 1,024 Â 1,024 pixels, with a pinhole diameter of 1 Airy unit for each emission channel. For terminal uridine deoxynucleotidyl transferase dUTP nick and labeling (TUNEL) assay in vivo, tissue specimens were fixed in 10% formalin for 12 to 24 h, dehydrated, and paraffin embedded. Detection of apoptosis at singlecell level based on labeling of DNA strand breaks was performed using the In Situ Cell Detection kit (Roche) following the manufacture instruction.
Real-time quantitative PCR. Real-time quantitative PCR (RTqPCR) primers were designed using Primer Express software. PCR assays were performed in 96-well optical reaction plates using the ABI 7500HT machine (Applied Biosystem). PCR assays were conducted in triplicate wells for each sample. Baseline values of amplification plots were set automatically, and threshold values were kept constant to obtain normalized cycle times and linear regression data. The reaction mixture per well used were as follows: 10 AL Power Syber Green (Applied Biosystem), 2.4 AL of primers at the final concentration of 150 nmol/L, 4.6 AL RNAase free water, and 3 AL cDNA (60 ng). For all experiments, PCR conditions used were as follows: denaturation at 95jC for 10 min, followed by 40 cycles at 95jC for 15 s, then at 60jC for 60 s. Quantitative normalization of cDNA in each sample was performed using cyclophilin as internal control. Relative quantification was performed using the DDC T method. Validated primers for RTqPCR are available upon request.
Statistical analysis. All results are expressed as mean F SE. Data distribution and gene expression statistical analysis were performed using NCSS statistical and power analysis software 2007. Multiple groups were tested by one-way ANOVA or two-ways ANOVA repeated measures where appropriate, followed by Fisher's least significant difference test for unpaired data. Comparisons of two groups were performed using a Student's t test followed by Mann-Whitney U test where appropriate. A P value of <0.05 was considered significant.
Results and Discussion
In the normal intestine, we found that FXR expression is highest in the fully differentiated cells of the surface epithelium (Fig. 1A) . To determine the role of FXR in transformed epithelium, we first examined the pattern of FXR expression in primary adenomas of mouse and human colon by immunohistochemistry and RTqPCR. FAP (8, 9 ) is a syndrome caused by mutations in the APC gene (10) and it is characterized by the early development of multiple polypoid tumors. In the mouse model of this disease (10), Apc Min/+ mice develop tumors primarily in the small intestine and at later stages within the colon. Furthermore, in this model, tumors progress from precursor lesions, known as ACFs to polypoid adenomas. The expression of FXR was reduced in the ACFs and in the tumors of Apc Min/+ mice (Fig. 1B) . Similarly, compared with the normal adjacent mucosa, FXR expression was significantly (Fig. 1B) . Thus, we conclude that FXR expression is low in mouse and human intestinal tumors compared with normal intestinal mucosa.
To understand if decreased FXR expression in tumors is simply a consequence of the lack of differentiation of transformed colonocytes, or if the loss of FXR contributes to tumor progression, we crossed pure strain C57BL/6J FXR À/À mice (6) with pure strain C57BL/6J Apc Min/+ mice (10) . Consistent with the latter, FXR À/À Apc Min/+ mice died at early age. Indeed, time of survival was directly proportional to the number of FXR alleles (Fig. 2A) . The number and size of tumors were quantitated in 4-to 6-monthold mice. A significant increase was seen in the number and size of tumors of FXR +/À
Apc
Min/+ mice relative to FXR +/+ Apc Min/+ mice (Supplementary Fig. S1; Fig. 2B ). Because FXR À/À
Min/+ mice die before the age of 3 months, they were not included in this tumor count. Nevertheless, upon macroscopic examination, the intestine of 7-to 8-week-old FXR À/À
Min/+ mice already contained numerous ACF and large regions of severely disrupted crypt and villus units with loss of cytoarchitecture and adenomalike lesions ( Fig. 2C; ref. 11 ). Upon histologic examination, these dysplastic regions presented an expansion of the basal, proliferative compartment (11) both in the ileum and in the colon, and a concomitant reduction in the apical, differentiated compartment (Fig. 2C) . It is known that mice lacking FXR have a compromised intestinal epithelial barrier with increased ileal levels of bacteria and numbers of neutrophils per villus (12) . Here, we found massive neutrophils and macrophages infiltration via CD18 labeling in the mucosa of FXR À/À Apc Min/+ mice with increased nuclear h-catenin accumulated and Ki67-positive epithelial cells (Fig. 2C and D) . Activated macrophages are able to further promote Wnt/h-catenin signaling and tumor development in the intestinal mucosa of Apc Min/+ mice through tumor necrosis factor-a (TNFa; ref. 13) , and TNFa blocking has been shown to reduce intestinal tumors in the azoxymethane (AOM)-dextran sulfate sodium (DSS) mouse model of colon carcinogenesis associated with chronic colitis (14) . Thus, we measured mRNA levels of TNFa and found a significant increase in expression in the ileum and colon of FXR À/À Apc Min/+ mice compared with FXR +/+ Apc Min/+ mice (Fig. 2D) . Consequently, we also tested the role of FXR in the AOM-DSS mouse model of intestinal tumorigenesis (14) . As in the Apc Min/+ model, the absence of FXR mice resulted in increased susceptibility to intestinal tumorigenic early events as shown by the increased number and size of colonic dysplastic areas per mouse compared with FXR +/+ mice (Supplementary Fig. S2; Fig. 3A) . Furthermore, FXR À/À mice showed higher sensitivity to the treatment regimen as shown by an increase in mortality (Fig. 3A) . From these results, we conclude that loss of FXR in two mouse models of intestinal tumorigenesis results in early mortality and tumor progression. Although the precise mechanism by which the loss of FXR results in increased tumor susceptibility is not completely clear, our data indicate that the promotion of Wnt signaling caused by increased TNFa production and mucosal infiltration of activated neutrophils and macrophages may play a contributing role. FXR À/À mice have an increased bile acid pool size due to increased hepatic bile acid synthesis (6, 15) . It has been suggested that bile acids contribute to hepatocellular carcinogenesis observed in the FXR À/À mice (16, 17) . Similarly, the high susceptibility of FXR À/À mice to intestinal tumorigenesis might relate to the elevated bile acid levels per se rather than a direct effect of the loss of FXR in the intestine. To this end, we performed two experiments with a diet containing 2% of the bile acid binding resin cholestyramine, which is able to significantly reduce the circulating 
Min/+ mice treated with cholestyraminecontaining diet versus chow diet (Fig. 3B) . Interestingly, although no ACFs were detected in the intestine of 2-month-old Apc Fig. S2; Fig. 3A ). These data suggest that, unlike the liver, the absence of FXR from the intestinal epithelium and not merely elevated bile acid concentrations per se increases susceptibility to tumorigenesis. Although these studies clearly established a connection between the loss of FXR and intestinal tumorigenesis, we sought to gain additional mechanistic insight and determine if and how FXR activation might protect against intestinal tumorigenesis using gain-of-function studies. VP16 is a strong transcriptional activator, and when expressed as a chimeric protein, VP16FXR results in the constitutive induction of FXR target genes. Our goal was to determine if reactivation of FXR in intestinal cancer cells was able to block tumor growth using a xenograft mouse model. To this end, we generated adenoviruses expressing the VP16 and VP16FXR chimeras. We injected LS174T colon cancer cells (11) s.c. in nude mice and followed tumor growth after administration of AdVP16 or AdVP16FXR. Activated FXR markedly increased apoptosis, as B, H&E, TUNEL, Ki67, P21, and FXR staining of the tumors revealed a net activation of apoptotic events with reduction in Ki67 labeling after administration of AdVP16FXR. C, when LS174T cells were infected with AdVP16FXR, significant increased mRNA levels of FXR target gene SHP were paralleled by an increase in the mRNA levels of a proapoptotic network of genes (FAS, BAK1, P21, KLF4, FADD, CASP9 , and P27 ) and a decrease in mRNA levels of antiapoptotic BCL2 and proinflammatory TNFa genes. Columns, mean of four independent determinations performed in duplicate; bars, SE. Cyclophilin was used as reference gene and values were normalized to data obtained from AdVP16 infection. *, P < 0.05.
shown by TUNEL assay (Fig. 4B) , reduced proliferation, as shown by the Ki67 labeling (Fig. 4B) , and significantly blocked tumor growth (Fig. 4A) . These results were confirmed in the xenograft model using a second colon cancer cell line (HT29; Supplementary Fig. S3 ). In line with this finding, FXR activation has been shown to regulate apoptosis also in the vasculature (19) and in breast cancer (20) . Compared with AdVP16, AdVP16FXR infection in LS174T cells induced an increase in apoptotic events, as shown by Annexin V labeling and nucleosome enrichment, paralleled by a decrease in BrdUrd incorporation (Supplementary Fig. S4A ). In addition, the synthetic FXR ligand GW4064 was also able to activate apoptosis both in the cellular model ( Supplementary  Fig. S4B ) and in the normal intestinal mucosa in vivo (Supplementary Fig. S5 ). An intriguing scenario arises when we started searching for the FXR-driven transcriptome to explain the observed phenotype. A significant increase in mRNA levels of proapoptotic genes (Fig. 4C) were observed in AdVP16FXR versus AdVP16 infected LS174T cells. At the same time, there was a significant decrease in mRNA levels of antiapoptotic BCL2 and proinflammatory TNFa genes, whereas no differences were observed in the mRNA levels of genes targeted by the nuclear h-catenin-TCF complexes (11) . Expression levels of the known FXR target gene small heterodimer partner (SHP) are reported as control. These data show that activation of FXR seems to block tumor growth and to induce in normal and transformed enterocytes a network of proapoptotic genes that are downregulated in tumors ( Supplementary Fig. S6 ) and are known to play key roles in cancer prevention.
In summary, our data suggest that it is unlikely that the tumorpromoting activity of bile acids occurs as a function of their ability to activate FXR in the intestine. However, FXR activity is relevant to the pathogenesis of intestinal cancer. Our gain-and loss-of-function studies support the hypothesis that FXR suppresses intestinal tumorigenesis. When FXR is absent, there is a promotion of Wnt signaling via increased infiltrating neutrophils and TNFa production with expansion of the basal proliferative compartment both in the ileum and in the colon, and a concomitant reduction in the apical, differentiated apoptosiscompetent compartment. This scenario leads to increased tumor progression and early mortality in mice. On the other hand, when FXR is activated in the differentiated normal enterocytes and in colon cancer cells, there is an induction of apoptosis and removal of genetically altered cells, which may otherwise progress to complete transformation. Thus, from a therapeutic standpoint, strategies aimed at reactivating FXR expression in colon tumors might be useful in the treatment of colon cancer.
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